Your Browser doesn't support essential functions this website requires.
Safari 9, IE 10, Opera Mini and UC Browser for Android are not supported.

About

Jessica Kovall, PA-C

I am a certified Physician Assistant, originally from New York. I originally worked in Urgent Care centers in upstate New York, Maryland and Hawaii. Once I switched to the Gastroenterology specialty, I knew I found my passion.

I have had the honor and privilege of training with multiple GI doctors, and have spent the last two years working with and learning from Dr. Gregory Wiener. I am excited to continue to grow as a gastroenterology provider and share my knowledge with my patients.

Further information about Jessica Kovall, PA-C

Undergraduate: Bachelor of Science in Biological Sciences, Minor in Chemistry, Pre-Medicine Concentration (August 2004 – May 2008)

Graduate: Arcadia University, Glenside, Pennsylvania, Master of Medical Science in Physician Assistant Studies (May 2011 – May 2013)

Professional Memberships and Certifications

  • California State License (April 2018- February 2022)
  • DEA (June 2016- December 2021)
  • Hawaii State License (May 2015- Current)
  • Maryland State License (August 2014- June 2015)
  • Certified DOT Medical Examiner by the FMCSA (July 2014- July 2024)
  • Certified by the National Commission on Certification of Physician Assistants (May 2013)
  • BLS and ACLS Certification – American Heart Association (Active: April 2012 – Current)
  • GCP (Expires: July 2021)

 

Clinical Activities

 

GW Research, Inc. Gastroenterology
Chula Vista, CA
July 2018 – Current

Physicians assistant working in busy gastroenterology clinic, providing outpatient consultation, followup services, and entering patients into drug trials. Involved in variety of GI related patient care with detailed history, physical examinations, development and implementation of treatment plans, prescription of medications, ordering and interpretation of laboratory tests and diagnostic studies. Evaluating and treating common GI complaints and managing chronic GI conditions (ie: IBS, IBD, Hepatitis B & C, Colitis,Cirrhosis, NASH, Gastroparesis.) Educating patients, conducting pre-op exams and follow up for GI procedures.

Hawaii Gastroenterology Specialists LLC, Gastroenterology
Aiea, HI
June 07, 2016- July 2018

  • Efficiently and accurately diagnose and treat common gastrointestinal complaints and manage chronic gastrointestinal conditions (ie: IBS, IBD, Hepatitis B & C, Colitis, Cirrhosis.)
  • Examine, diagnose and treat 18-24 adult patients daily, in a busy outpatient clinic
  • Rapidly became expert user of GMED EMR system, reputation for thorough charts
  • Provide exceptional care showcased through positive feedback/patient satisfaction and multiple
    reviews, resulting in a high degree of patient loyalty
  • Responsible for investigating and resolving patient complaints/incidents in a proactive and professional manner
  • Communicate and collaborate with gastrointestinal team, including medical assistants, office
    managers, ultrasound technician and five supervising physicians
  • Communicate and collaborate with referring physicians, specialty physicians, pharmacists and
    radiologists

The Medical Corner, Urgent Care
Kailua, HI
October 2015 – July 2016

  • Examine, diagnose and treat 20-30 patients/day (all ages), as solo provider
  • Perform minor procedures including suturing, wound care, minor orthopedic injury assessment and
    treatment, splint application, foreign body removal, nail excision, I&D of abscess and more
  • Served as the local community college health provider
  • Experience with eye exam using fluorescein and woods light, pelvic examinations and microscopic examination with KOH prep
  • Certified to perform DOT physicals; also experience with Occupational Health and Workers Compensation

Comp Health Travel, Urgent Care
Kaiser Permanente Hawaii
July 2015-September 2015

  • Examine, diagnose and treat 20-30 patients/day (all ages), as solo provider
  • Perform minor procedures including suturing, wound care, minor orthopedic injury assessment and treatment, splint application, foreign body removal, nail excision, I&D of abscess and more
  • Served as the local community college health provider
  • Experience with eye exam using fluorescein and woods light, pelvic examinations and microscopic examination with KOH prep

Righttime Medical Care, Urgent Care
Annapolis, MD
November 2014 – June 2015

  • Examine, diagnose and treat 30-40 patients/day (all ages), as solo provider, and 40-80 patients/day
    (all ages), collaborating with another provider
  • Perform minor procedures including suturing, wound care, minor orthopedic injury assessment and
    treatment, splint application, foreign body removal, nail excision, I&D of abscess and more
  • Trained as provider for HeadFirst Concussion Clinic, one of the nation’s largest concussion clinics
  • Recommendations of subspecialists, consultants, referrals to the ER

North Country Urgent Care, Urgent Care
Watertown, NY
August 2013- November 2014
Supervising Physician: Dr. Walter Minaert

  • Examine, diagnose and treat 20-40 patients/day (all ages), as solo provider
  • Perform minor procedures including suturing, wound care, minor orthopedic injury assessment and
    treatment, splint application, foreign body removal, nail excision, I&D of abscess and more
  • Served as the local community college health provider
  • Experience with eye exam using fluorescein and woods light, pelvic examinations and microscopic examination with KOH prep
  • Certified to perform DOT physicals; also experience with Occupational Health and Workers Compensation


Clinical Research

Sub-Investigator: A Safety and Efficacy Comparison of BLI4700 Bowel Preparation versus an FDA-approved Comparator in Adult Subjects prior to Colonoscopy July 2018 – November 2018 (12 Screened/12 Randomized) one of top enrolling sites

 

Sub-Investigator: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis July 2018 – ongoing (6 Screened)

 

Sub-Investigator: RLM-MD-02: A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis July 2018 – ongoing (23 Screened)

 

Sub-Investigator: RLM-MD-03: A 46-week, Double-blind, Placebo-controlled, Phase 3 Study with a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis July 2018 – ongoing (3 randomized rollovers)

 

Sub-Investigator: RLM-MD-04: A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis July 2018 – ongoing (10 screened)

 

Sub-Investigator: MCP-103-312: A Phase 3b, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide 290 μg Administered Orally for 12 Weeks in Patients with Irritable Bowel Syndrome with Constipation July 2018 – ongoing (30 screened/16 randomized)

 

Sub-Investigator: C3718-301: A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors September 2018 – ongoing (22 screened)

 

Sub-Investigator: Protocol G28-006: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients with Lactose Intolerance August 2018 – ongoing (22 screened)

 

Sub-Investigator: 3152-301-002 – AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic November 2018 – ongoing (7 screened)

 

Sub-Investigator: VP-VLY-686-3301Vanda: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy of Tradipitant in Relieving Symptoms of Gastroparesis November 2019 – ongoing (8 screened)

 

Sub-Investigator: Phathom Pharmaceuticals, Inc. A Phase 3, Randomized, Double-Blind, Two-Phase, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 20 mg Compared to Lansoprazole 30 mg for Healing in Patients with Erosive Esophagitis and to Evaluate the Efficacy and Safety of Vonoprazan (10 mg and 20 mg) Compared to Lansoprazole 15 mg for the Maintenance of Healing in Patients with Healed Erosive Esophagitis November 2019 – ongoing (3 screened)

 

Sub-Investigator: 2018-10, An Evaluation of a Multi-target Stool DNA (mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now October 2019 – ongoing (47 screened)

 

Sub-Investigator: PBGD 1001, An Open Label, Multicenter Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Patients with Functional Gastrointestinal Disturbances, October 2019- December 2019 (20 screened / 20 randomized)

 

Sub-Investigator: Genentech, Inc. GC41033A Phase II, randomized, parallel-group, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety, and pharmacokinetics of bfkb8488a compared with placebo in patients with non-alcoholic steatohepatitis, February 2019

 

Sub-Investigator: APD371 202, A Phase 2, Multi Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study to Evaluate the Safety, Tolerability, and Efficacy of Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain, February 2019

 

Sub-Investigator: Braintree Protocol BLI4900-302, A Safety and Efficacy Comparison of BLI4900 Bowel Preparation versus an FDA-approved Comparator in Adult Subjects prior to Colonoscopy, February 2019

 

Sub-Investigator: Allakos, Inc., A Prospective Study to Identify the Incidence of Eosinophilic Gastrointestinal Diseases and Elevated Tissue Mast Cells among Patients with Chronic Gastrointestinal Symptoms, March 2019

 

Sub-Investigator: Exact Sciences Act Fast 2018-07, Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion, April 2019

 

SCHEDULE YOUR APPOINTMENT NOW!

Let's

Talk

English English Spanish Spanish